Jim Cramer’s 11 Stock Calls Including Marvell and Trane, and Caution About Overhyped AI Stocks
In this article, we will look at Jim Cramer’s Mad Money stock calls as he urged investors to exercise caution when it comes to red-hot AI stocks.
Design Therapeutics Inc. (DSGN)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | SR One Capital Simeon George | 6,526,476 | $94,438,108 | 9.09% | |
| 2. | Logos Capital Arsani William | 3,000,000 | $43,410,000 | +54% | 1.87% |
| 3. | Baker Bros. Advisors Julian Baker And Felix Baker | 2,678,430 | $38,756,882 | +4% | 0.19% |
| 4. | Driehaus Capital Richard Driehaus | 2,661,115 | $38,506,334 | +53% | 0.22% |
| 5. | Point72 Asset Management Steve Cohen | 2,366,453 | $34,242,575 | -14% | 0.04% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.74 | 17,809 | $66,605.66 | 26,965 | 2024-03-25 | Filing | |
| $3.62 | 9,156 | $33,132.82 | 9,156 | 2024-03-22 | Filing | |
| $3.74 | 1,300 | $4,865.77 | 1,300 | 2024-03-25 | Filing | |
| $2.35 | 21,000 | $49,287.00 | 133,024 | 2023-09-29 | Filing | |
| $20.00 | 700,000 | $14,000,000.00 | 700,000 | 2021-03-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.25 | 217,627 | $1,142,541.75 | 1,000,000 | 2025-08-13 | Filing | |
| $5.25 | 345,000 | $1,811,250.00 | 2,655,000 | 2025-08-13 | Filing | |
| $6.27 | 3,806 | $23,863.62 | 20,000 | 2024-12-18 | Filing | |
| $4.25 | 814,874 | $3,463,214.50 | 0 | 2024-08-09 | Filing | |
| $18.63 | 1,455 | $27,105.49 | 4,129,950 | 2022-03-22 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,660,024 | $38,490,551 | 0% | |
| 2. | 1,809,854 | $26,188,587 | 0.57% | |
| 3. | 1,571,022 | $22,732,688 | 0% | |
| 4. | 1,500,000 | $21,705,000 | 0.1% | |
| 5. | 1,118,098 | $16,178,878 | 0.08% |
News See All
Design Therapeutics, Inc. (NASDAQ:DSGN) Q4 2023 Earnings Call Transcript
Design Therapeutics, Inc. (NASDAQ:DSGN) Q4 2023 Earnings Call Transcript March 19, 2024 Design Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.21, expectations were $-0.32.